Serological tests suffer poor sensitivity and specificity at the early stage of HCC, as the AFP level is associated with both HCC and chronic liver disease.6,7 There is therefore a great urgency to improve early diagnosis of HCC, and also to identify and validate new potential therapeutic targets. Here, AFP is linked to hepatocellular carcinoma.